Big Verdict in 1st Risperdal Trial

Pennsylvania Jury Awards $2.5 Million in Risperdal Case
In the first trial of more than 1,250 cases pending in Philadelphia courts, the jury returned a verdict against Risperdal manufacturer, Janssen Pharmaceuticals in the amount of $2.5 million. The Plaintiff, in this case, took Risperdal to treat behavioral problems associated with autism. He developed gynecomastia, which is a condition where males develop enlarged breasts. Gynecomastia is painful and can require surgery. The amount of the verdict speaks to the jury’s shock that Janssen Pharmaceuticals failed to warn young men and their parents that the gynecomastia side effect could occur.

Risperdal is Dangerous! No Matter Where You Live, Contact Our Georgia Risperdal Lawyers to Discuss Options at (770) 727-5550
Risperdal is an antipsychotic medication made by Janssen, a subsidiary of Johnson & Johnson, to treat behavioral disorders such as bipolar disorder, schizophrenia, and irritability in autism patients. The large pharmaceutical company made billions of dollars from the drug despite its dangers. If you know of a young man treated with Risperdal that developed abnormally large breast, please contact our Georgia Risperdal Breast Growth Attorneys.

Proven. Personal. Parian.